Regulation of hepatocarcinogenesis by MicroRNAs

Frontiers in Bioscience - Elite

Volumn 5 E, Issue 1, 2013, Pages 49-60

  Wong, Chun Ming ^a   Kai, Alan Ka Lun ^a   Tsang, Felice Ho Ching ^a   Ng, Irene Oi Lin ^a  

^a THE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Carcinogenesis; Hepatocellular carcinoma; MicroRNA; Pathology; Review

Indexed keywords

MICRO RNA 139; MICRO RNA 17 92; MICRO RNA 30D; MICRO RNA LET 7G; MICRORNA; MICRORNA 101; MICRORNA 122; MICRORNA 125B; MICRORNA 21; MICRORNA 221; MICRORNA 222; MICRORNA 29; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT;

BIOGENESIS; CANCER DIAGNOSIS; CANCER PROGNOSIS; DIAGNOSTIC TEST ACCURACY STUDY; GENE OVEREXPRESSION; HUMAN; LIVER CANCER; LIVER CARCINOGENESIS; NONHUMAN; ONCOGENE; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; RNA SEQUENCE; BIOSYNTHESIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC VARIABILITY; GENETICS; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; METHODOLOGY; PHYSIOLOGY; PROGNOSIS;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

CARCINOMA, HEPATOCELLULAR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VARIATION; HUMANS; LIVER NEOPLASMS; MICRORNAS; PROGNOSIS;

MLCS; MLOWN;

EID: 84878504160     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: 10.2741/e595     Document Type: Review

References (47)

1. D. M. Parkin, F. Bray, J. Ferlay and P. Pisani: Estimating the world cancer burden: Globocan 2000. Int J Cancer, 94(2), 153-6 (2001) (Pubitemid 32911406)
2. C. M. Wong and I. O. Ng: Molecular pathogenesis of hepatocellular carcinoma. Liver Int, 28(2), 160-74 (2008) (Pubitemid 351201031)
3. C. M. Croce: Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet, 10(10), 704-14 (2009)
4. H. K. Saini, S. Griffiths-Jones and A. J. Enright: Genomic analysis of human microRNA transcripts. Proc Natl Acad Sci U S A, 104(45), 17719-24 (2007) (Pubitemid 350210901)
5. D. P. Bartel: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116(2), 281-97 (2004)
6. V. Ambros: microRNAs: tiny regulators with great potential. Cell, 107(7), 823-6 (2001) (Pubitemid 34084973)
7. P. Maziere and A. J. Enright: Prediction of microRNA targets. Drug Discov Today, 12(11-12), 452-8 (2007) (Pubitemid 46795589)
8. A. E. Williams: Functional aspects of animal microRNAs. Cell Mol Life Sci, 65(4), 545-62 (2008) (Pubitemid 351297689)
9. A. Eulalio, E. Huntzinger, T. Nishihara, J. Rehwinkel, M. Fauser and E. Izaurralde: Deadenylation is a widespread effect of miRNA regulation. RNA, 15(1), 21-32 (2009)
10. I. Bentwich, A. Avniel, Y. Karov, R. Aharonov, S. Gilad, O. Barad, A. Barzilai, P. Einat, U. Einav, E. Meiri, E. Sharon, Y. Spector and Z. Bentwich: Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet, 37(7), 766-70 (2005) (Pubitemid 41754896)
11. S. Wu, S. Huang, J. Ding, Y. Zhao, L. Liang, T. Liu, R. Zhan and X. He: Multiple microRNAs modulate p21Cip1/Waf1 expression by directly targeting its 3' untranslated region. Oncogene, 29(15), 2302-8 (2010)
12. Y. Murakami, T. Yasuda, K. Saigo, T. Urashima, H. Toyoda, T. Okanoue and K. Shimotohno: Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene, 25(17), 2537-45 (2006)
13. L. Gramantieri, M. Ferracin, F. Fornari, A. Veronese, S. Sabbioni, C. G. Liu, G. A. Calin, C. Giovannini, E. Ferrazzi, G. L. Grazi, C. M. Croce, L. Bolondi and M. Negrini: Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res, 67(13), 6092-9 (2007) (Pubitemid 47037488)
14. S. M. Johnson, H. Grosshans, J. Shingara, M. Byrom, R. Jarvis, A. Cheng, E. Labourier, K. L. Reinert, D. Brown and F. J. Slack: RAS is regulated by the let-7 microRNA family. Cell, 120(5), 635-47 (2005) (Pubitemid 40343076)
15. J. Takamizawa, H. Konishi, K. Yanagisawa, S. Tomida, H. Osada, H. Endoh, T. Harano, Y. Yatabe, M. Nagino, Y. Nimura, T. Mitsudomi and T. Takahashi: Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer research, 64(11), 3753-6 (2004) (Pubitemid 38697282)
16. S. Volinia, G. A. Calin, C. G. Liu, S. Ambs, A. Cimmino, F. Petrocca, R. Visone, M. Iorio, C. Roldo, M. Ferracin, R. L. Prueitt, N. Yanaihara, G. Lanza, A. Scarpa, A. Vecchione, M. Negrini, C. C. Harris and C. M. Croce: A microRNA expression signature of human solid tumors defines cancer gene targets.. Proc Natl Acad Sci U S A, 103(7), 2257-61 (2006) (Pubitemid 43271657)
17. H. He, K. Jazdzewski, W. Li, S. Liyanarachchi, R. Nagy, S. Volinia, G. A. Calin, C. G. Liu, K. Franssila, S. Suster, R. T. Kloos, C. M. Croce and A. de la Chapelle: The role of microRNA genes in papillary thyroid carcinoma.. Proc Natl Acad Sci USA, 102(52), 19075-80 (2005) (Pubitemid 43049568)
18. P. Pallante, R. Visone, M. Ferracin, A. Ferraro, M. T. Berlingieri, G. Troncone, G. Chiappetta, C. G. Liu, M. Santoro, M. Negrini, C. M. Croce and A. Fusco: MicroRNA deregulation in human thyroid papillary carcinomas. Endocrine-related cancer, 13(2), 497-508 (2006) (Pubitemid 43886672)
19. A. M. Liu, C. Zhang, J. Burchard, S. T. Fan, K. F. Wong, H. Dai, R. T. Poon and J. M. Luk: Global regulation on microRNA in hepatitis B virus-associated hepatocellular carcinoma. OMICS, 15(3), 187-91 (2011)
20. J. Jiang, Y. Gusev, I. Aderca, T. A. Mettler, D. M. Nagorney, D. J. Brackett, L. R. Roberts and T. D. Schmittgen: Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin Cancer Res, 14(2), 419-27 (2008) (Pubitemid 351226109)
21. E. J. Lee, Y. Gusev, J. Jiang, G. J. Nuovo, M. R. Lerner, W. L. Frankel, D. L. Morgan, R. G. Postier, D. J. Brackett and T. D. Schmittgen: Expression profiling identifies microRNA signature in pancreatic cancer. International journal of cancer. Journal international du cancer, 120(5), 1046-54 (2007) (Pubitemid 46214304)
22. M. V. Iorio, M. Ferracin, C. G. Liu, A. Veronese, R. Spizzo, S. Sabbioni, E. Magri, M. Pedriali, M. Fabbri, M. Campiglio, S. Menard, J. P. Palazzo, A. Rosenberg, P. Musiani, S. Volinia, I. Nenci, G. A. Calin, P. Querzoli, M. Negrini and C. M. Croce: MicroRNA gene expression deregulation in human breast cancer. Cancer research, 65(16), 7065-70 (2005) (Pubitemid 41161233)
23. J. A. Chan, A. M. Krichevsky and K. S. Kosik: MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer research, 65(14), 6029-33 (2005) (Pubitemid 40994386)
24. P. Pineau, S. Volinia, K. McJunkin, A. Marchio, C. Battiston, B. Terris, V. Mazzaferro, S. W. Lowe, C. M. Croce and A. Dejean: miR-221 overexpression contributes to liver tumorigenesis. Proc Natl Acad Sci USA, 107(1), 264-9 (2010)
25. W. Wang, B. Peng, D. Wang, X. Ma, D. Jiang, J. Zhao and L. Yu: Human tumor MicroRNA signatures derived from large-scale oligonucleotide microarray datasets. International journal of cancer Journal international du cancer (2010)
26. F. Meng, R. Henson, M. Lang, H. Wehbe, S. Maheshwari, J. T. Mendell, J. Jiang, T. D. Schmittgen and T. Patel: Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology, 130(7), 2113-29 (2006) (Pubitemid 43816961)
27. F. Meng, R. Henson, H. Wehbe-Janek, K. Ghoshal, S. T. Jacob and T. Patel: MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology, 133(2), 647-58 (2007) (Pubitemid 47187346)
28. S. A. Ciafre, S. Galardi, A. Mangiola, M. Ferracin, C. G. Liu, G. Sabatino, M. Negrini, G. Maira, C. M. Croce and M. G. Farace: Extensive modulation of a set of microRNAs in primary glioblastoma. Biochemical and biophysical research communications, 334(4), 1351-8 (2005) (Pubitemid 41074723)
29. N. Felli, L. Fontana, E. Pelosi, R. Botta, D. Bonci, F. Facchiano, F. Liuzzi, V. Lulli, O. Morsilli, S. Santoro, M. Valtieri, G. A. Calin, C. G. Liu, A. Sorrentino, C. M. Croce and C. Peschle: MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation.. Proc Natl Acad Sci U S A, 102(50), 18081-6 (2005) (Pubitemid 41798505)
30. F. Gottardo, C. G. Liu, M. Ferracin, G. A. Calin, M. Fassan, P. Bassi, C. Sevignani, D. Byrne, M. Negrini, F. Pagano, L. G. Gomella, C. M. Croce and R. Baffa: Micro-RNA profiling in kidney and bladder cancers. Urologic oncology, 25(5), 387-92 (2007) (Pubitemid 47362758)
31. F. Fornari, L. Gramantieri, M. Ferracin, A. Veronese, S. Sabbioni, G. A. Calin, G. L. Grazi, C. Giovannini, C. M. Croce, L. Bolondi and M. Negrini: MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. Oncogene, 27(43), 5651-61 (2008)
32. L. Gramantieri, F. Fornari, M. Ferracin, A. Veronese, S. Sabbioni, G. A. Calin, G. L. Grazi, C. M. Croce, L. Bolondi and M. Negrini: MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality. Clin Cancer Res, 15(16), 5073-81 (2009)
33. A. M. Hui, L. Sun, Y. Kanai, M. Sakamoto and S. Hirohashi: Reduced p27Kip1 expression in hepatocellular carcinomas. Cancer letters, 132(1-2), 67-73 (1998) (Pubitemid 28535186)
34. K. J. Nan, H. Guo, Z. P. Ruan, Z. Jing and S. X. Liu: Expression of p57 (kip2) and its relationship with clinicopathology, PCNA and p53 in primary hepatocellular carcinoma. World journal of gastroenterology: WJG, 11(8), 1237-40 (2005) (Pubitemid 40353015)
35. K. J. Nan, Z. Jing and L. Gong: Expression and altered subcellular localization of the cyclin-dependent kinase inhibitor p27Kip1 in hepatocellular carcinoma. World journal of gastroenterology: WJG, 10(10), 1425-30 (2004) (Pubitemid 39206804)
36. S. Nakai, T. Masaki, Y. Shiratori, T. Ohgi, A. Morishita, K. Kurokohchi, S. Watanabe and S. Kuriyama: Expression of p57 (KIP2) in hepatocellular carcinoma: relationship between tumor differentiation and patient survival. International journal of oncology, 20(4), 769-75 (2002)
37. Q. W.-L. Wong, A. K.-K. Ching, A. W.-H. Chan, K.-W. Choy, K.-F. To, P. B.-S. Lai and N. Wong: MiR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling. Clin Cancer Res, 16(3), 867-75 (2010)
38. C. Coulouarn, V. M. Factor, J. B. Andersen, M. E. Durkin and S. S. Thorgeirsson: Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties. Oncogene, 28(40), 3526-36 (2009)
39. Y. Xiong, J.-H. Fang, J.-P. Yun, J. Yang, Y. Zhang, W.-H. Jia and S.-M. Zhuang: Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma. Hepatology, 51(3), 836-45 (2010)
40. A. Budhu, H. L. Jia, M. Forgues, C. G. Liu, D. Goldstein, A. Lam, K. A. Zanetti, Q. H. Ye, L. X. Qin, C. M. Croce, Z. Y. Tang and X. W. Wang: Identification of metastasis-related microRNAs in hepatocellular carcinoma. Hepatology, 47(3), 897-907 (2008) (Pubitemid 351449681)
41. J. Yang, F. Zhou, T. Xu, H. Deng, Y.-Y. Ge, C. Zhang, J. Li and S.-M. Zhuang: Analysis of sequence variations in 59 microRNAs in hepatocellular carcinomas. Mutat Res, 638(1-2), 205-9 (2008)
42. F. Sato, E. Hatano, K. Kitamura, A. Myomoto, T. Fujiwara, S. Takizawa, S. Tsuchiya, G. Tsujimoto, S. Uemoto and K. Shimizu: MicroRNA profile predicts recurrence after resection in patients with hepatocellular carcinoma within the Milan Criteria. PLoS One, 6(1), e16435 (2011)
43. T. Sukata, K. Sumida, M. Kushida, K. Ogata, K. Miyata, S. Yabushita and S. Uwagawa: Circulating microRNAs, possible indicators of progress of rat hepatocarcinogenesis from early stages. Toxicol Lett, 200(1-2), 46-52 (2011)
44. K. Z. Qu, K. Zhang, H. Li, N. H. Afdhal and M. Albitar: Circulating MicroRNAs as Biomarkers for Hepatocellular Carcinoma. J Clin Gastroenterol (2011)
45. J. Weiler, J. Hunziker and J. Hall: Anti-miRNA oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease? Gene Ther, 13(6), 496-502 (2006)
46. M. S. Ebert, J. R. Neilson and P. A. Sharp: MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods, 4(9), 721-6 (2007) (Pubitemid 47338166)
47. K. Gumireddy, D. D. Young, X. Xiong, J. B. Hogenesch, Q. Huang and A. Deiters: Small-molecule inhibitors of microrna miR-21 function. Angew Chem Int Ed Engl, 47(39), 7482-4 (2008)